IVIG effective option for refractory polymyositis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1334, 2002-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 4, 2005-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Anti-TNF- therapy successful in refractory polymyositis

By  

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

IVIG cost-effective treatment for mucous membrane pemphigoid

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

IV immunoglobulin (IVIG) is a valid maintenance therapy option for myasthenia gravis

By  

Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Nortriptyline: effective option for smoking cessation

By  

Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite